Skip to main content

Drs. David Barber, Michael Green, and Catherine Donnelly (OT) are co-investigators on a $1.4-million project titled Determining the Impact of a Physiotherapist-Led Primary Care Model for Low Back Pain - A Cluster Randomized Controlled Trial.     

Dr. Imaan Bayoumi Receives SEAMO Innovation Fund Award

Dr. Imaan Bayoumi has received a SEAMO Innovation Fund award for her research, Targeting Child Mental Health and Household Poverty: Impact of a Poverty Intervention in Primary Care on Preschool Children’s Emotional and Behavioural Health. This pilot study was funded for $99,960 from 2019-2021. Recruitment is currently underway at the Queen's Family Health Team. 

Dr. Joey Newbigging Earns PARO Teaching Award

Dr. Joey Newbigging, Program Director, Enhanced Skills Emergency Medicine, has earned this year’s Professional Association of Residents of Ontario (PARO) Excellence in Clinical Teaching Award for Queen’s University. This award acknowledges the essential role good clinical teachers play in the training of new physicians.

Opioids, Addictions, Focus of Horizons

Dr. Eva Purkey, Global Health Director, is pleased to present the Spring/Summer 2019 issue of Horizons, the department’s twice-annual global health publication. This issue focuses on Opioids and Addictions. (Posted March 2019)

Belleville Team Co-Investigators on CIHR Grant

Occupational Therapists Dr. Catherine Donnelly and Nicole Bobbette, and Pharmacist Dr. Stephanie Lynch,  all from the Queen’s Family Health Team Belleville Site, are co-investigators on a CIHR Operating Grant ($100,000) for Evaluating the Outcomes and Experiences Of Chronic Pain Self-Management Support with an Opioid De-Prescribing Intervention: A Mixed Methods Study. (Posted March 2019)

Dr. Dave Barber Co-Investigator on $1M Project to Help Brain Injury Patients

Dr. Dave Barber is co-investigator on a $1M project that will help frail and elderly patients diagnosed with a traumatic brain injury. The project team will design and implement an imaging technology that will evaluate the presence of bleeding on or in the brain of patients awaiting CT imaging.